NeuPath Health (NPTH) investor relations material

Executive summary

• Operates 12 regulated medical facilities in Alberta and Ontario, focusing on MSK and chronic pain, with 150 healthcare professionals and 200,000 annual patient visits.

• Achieved record first quarter total revenue of $21.5 million, up 11% year-over-year, driven by increased patient visits and expanded service offerings.

• Adjusted EBITDA rose 15% year-over-year to $1.5 million, reflecting operational improvements and higher capacity utilization.

• New CEO Stephen Lemieux appointed on April 1, 2026, with a focus on profitability and strategic growth.

• Expansion efforts include onboarding new physicians and opening a new location in Guelph, Ontario, expected in late Q3.

Financial highlights

• Q1 2026 revenue increased 11% year-over-year to CAD 21.5 million.

• Adjusted EBITDA rose 15% to CAD 1.5 million, outpacing revenue growth.

• Clinic revenue grew 12% year-over-year, though gross margin declined slightly due to increased staffing and training costs.

• Gross margin was $3.96 million (18.4% of revenue), slightly down from 18.8% in Q1 2025.

• Cash and cash equivalents stood at $3.5 million, with long-term debt of $6.0 million as of March 31, 2026.

Outlook and guidance

• Plans to onboard 6–8 additional physicians in 2026, in addition to 2 already onboarded in Q1.

• Continued focus on expanding physician hours, leveraging technology and AI for efficiency.

• Active M&A pipeline with mid-to-late stage discussions in BC, Alberta, and Ontario.

• Management expects continued operational improvements and execution of growth opportunities throughout 2026.

• Q2 is typically the strongest quarter, but prior year included a one-time payment adjustment.